TJAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.834300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.416050E-01
Normal-vs-Stage2
4.790100E-02
Normal-vs-Stage3
7.701800E-02
Normal-vs-Stage4
2.943200E-01
Stage1-vs-Stage2
9.711600E-01
Stage1-vs-Stage3
1.579020E-01
Stage1-vs-Stage4
6.128800E-01
Stage2-vs-Stage3
1.239190E-01
Stage2-vs-Stage4
6.671200E-01
Stage3-vs-Stage4
9.964000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.429900E-02
Normal-vs-AfricanAmerican
2.359200E-01
Normal-vs-Asian
3.815400E-01
Caucasian-vs-AfricanAmerican
3.951000E-01
Caucasian-vs-Asian
2.798400E-01
AfricanAmerican-vs-Asian
1.537800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.644200E-02
Normal-vs-Female
8.067900E-02
Male-vs-Female
4.756400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.153400E-01
Normal-vs-Age(41-60Yrs)
5.021700E-02
Normal-vs-Age(61-80Yrs)
5.635600E-02
Normal-vs-Age(81-100Yrs)
1.011840E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.563600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.225200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.026600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.427650E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.118600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.841400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.416200E-02
Normal-vs-Daily Drinker
1.725660E-02
Normal-vs-Weekly Drinker
3.597200E-01
Normal-vs-Occasional Drinker
2.336000E-01
Normal-vs-Social Drinker
9.256000E-02
Non Drinker-vs-Daily Drinker
3.132800E-01
Non Drinker-vs-Weekly Drinker
2.973800E-01
Non Drinker-vs-Occasional Drinker
4.192400E-01
Non Drinker-vs-Social Drinker
9.331000E-01
Daily Drinker-vs-Weekly Drinker
6.768200E-02
Daily Drinker-vs-Occasional Drinker
9.140100E-02
Daily Drinker-vs-Social Drinker
4.112800E-01
Weekly Drinker-vs-Occasional Drinker
7.786400E-01
Weekly Drinker-vs-Social Drinker
3.340200E-01
Occasional Drinker-vs-Social Drinker
4.404800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.870800E-01
Normal-vs-Grade 2
6.858200E-01
Normal-vs-Grade 3
7.054400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.283360E-01
Grade 1-vs-Grade 3
2.693200E-01
Grade 1-vs-Grade 4
4.870800E-01
Grade 2-vs-Grade 3
6.922800E-01
Grade 2-vs-Grade 4
6.858200E-01
Grade 3-vs-Grade 4
7.054400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.717700E-02
Normal-vs-NonDiabetic
8.591900E-02
Diabetic-vs-NonDiabetic
9.940200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.530230E-01
Normal-vs-NoPancreatitis
5.749500E-02
Pancreatitis-vs-NoPancreatitis
4.712000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.795800E-02
Normal-vs-N1
3.528000E-02
N0-vs-N1
3.954000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.474610E-01
Normal-vs-TP53-NonMutant
1.260180E-01
TP53-Mutant-vs-TP53-NonMutant
9.078000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
